Literature DB >> 28035851

Shifting from Correlation to Causation: Challenges for the Future of Unbiased Molecular Studies in Inflammatory Lung Disease.

Stephanie A Christenson1, Katrina Steiling2,3.   

Abstract

Mesh：

Year:  2017        PMID： 28035851      PMCID： PMC5439941          DOI： 10.1164/rccm.201608-1751ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  21 in total

1.  MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.

Authors:  Geert R Van Pottelberge; Pieter Mestdagh; Ken R Bracke; Olivier Thas; Yannick M T A van Durme; Guy F Joos; Jo Vandesompele; Guy G Brusselle
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

2.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

Authors:  Prescott G Woodruff; R Graham Barr; Eugene Bleecker; Stephanie A Christenson; David Couper; Jeffrey L Curtis; Natalia A Gouskova; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Stephen C Lazarus; Fernando J Martinez; Robert Paine; Stephen Rennard; Donald P Tashkin; MeiLan K Han
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

3.  IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.

Authors:  Abraham B Roos; Caroline Sandén; Michiko Mori; Leif Bjermer; Martin R Stampfli; Jonas S Erjefält
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

4.  International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

Authors:  A Sonia Buist; Mary Ann McBurnie; William M Vollmer; Suzanne Gillespie; Peter Burney; David M Mannino; Ana M B Menezes; Sean D Sullivan; Todd A Lee; Kevin B Weiss; Robert L Jensen; Guy B Marks; Amund Gulsvik; Ewa Nizankowska-Mogilnicka
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 5.  Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications.

Authors:  Yohan Bossé
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

Review 6.  MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Carlo M Croce
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

7.  Persistence of smoking-induced dysregulation of miRNA expression in the small airway epithelium despite smoking cessation.

Authors:  Guoqing Wang; Rui Wang; Yael Strulovici-Barel; Jacqueline Salit; Michelle R Staudt; Joumana Ahmed; Ann E Tilley; Jenny Yee-Levin; Charleen Hollmann; Ben-Gary Harvey; Robert J Kaner; Jason G Mezey; Sriram Sridhar; Sreekumar G Pillai; Holly Hilton; Gerhard Wolff; Hans Bitter; Sudha Visvanathan; Jay S Fine; Christopher S Stevenson; Ronald G Crystal
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

8.  miR-638 regulates gene expression networks associated with emphysematous lung destruction.

Authors:  Stephanie A Christenson; Corry-Anke Brandsma; Joshua D Campbell; Darryl A Knight; Dmitri V Pechkovsky; James C Hogg; Wim Timens; Dirkje S Postma; Marc Lenburg; Avrum Spira
Journal:  Genome Med       Date:  2013-12-31       Impact factor: 11.117

Review 9.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

10.  MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression.

Authors:  Santiyagu M Savarimuthu Francis; Morgan R Davidson; Maxine E Tan; Casey M Wright; Belinda E Clarke; Edwina E Duhig; Rayleen V Bowman; Nicholas K Hayward; Kwun M Fong; Ian A Yang
Journal:  BMC Genomics       Date:  2014-01-30       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.